The AIM with Immunotherapy Initiative – Home › Forums › Immunotherapy › Dosing and administration › Infusion times › Reply To: Infusion times
February 2, 2018 at 3:56 pm #4648
Expert NurseVirginia Seery
I agree with Krista that we have seen a big increase in volume with nivolumab now being used in the adjuvant setting. We still give ipilimumab over 90 minutes, nivolumab over 60 minutes and pembrolizumab over 30 minutes. It sounds like we are behind with adjusting infusion times, but I will talk with our pharmacy about adjusting them. Thanks for the tip!